ZaBeCor forms unit to devise treatments for blood, lymphatic cancers

09/25/2008 | Philadelphia Inquirer, The

ZaBeCor Pharmaceuticals has established Biothorpe Pharmaceuticals, a unit that will develop molecular technologies aimed at treating cancers such as acute myelogenous leukemia and B-cell lymphoma. The biotech subsidiary will concentrate its efforts on Syk kinase, a substance that has been found to play a role in the growth of malignant cells in various cancers.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX